CovalX

New Benchtop MALDI-TOF Mass Spectrometer Featuring Integrated MegaDalton Ion Detection

Retrieved on: 
Monday, April 4, 2022
Unit, Polymer, Scientific instrument, SSI, Government, University, Oligonucleotide, Analytic, Incidence, Immunoglobulin A, MALDI, Laboratory, Vacuum, Shimadzu, Innovation, Immunoglobulin G, Innovation Center station, Industry, Technology, Protein, Cross-linking, Science, Solution, Efficiency, Immunoglobulin M, CovalX, Peptide, Acquisition, Medical imaging, Microscope

COLUMBIA, Md., April 4, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments, in collaboration with CovalX Instruments Inc., introduces the OmegaTOF benchtop high mass matrix-assisted laser desorption ionization–time-of-flight (MALDI-TOF) mass spectrometer. The OmegaTOF system couples Shimadzu's benchtop MALDI-TOF instrument platform (MALDI-8020) with established technology for high mass detection from CovalX. The result is a user-friendly, compact platform that extends benchtop MALDI-TOF analysis to a mass range of 1.5 MegaDalton.

Key Points: 
  • The OmegaTOF system couples Shimadzu's benchtop MALDI-TOF instrument platform (MALDI-8020) with established technology for high mass detection from CovalX.
  • COLUMBIA, Md., April 4, 2022 /PRNewswire-PRWeb/ -- Shimadzu Scientific Instruments, in collaboration with CovalX Instruments Inc., introduces the OmegaTOF benchtop high mass matrix-assisted laser desorption ionizationtime-of-flight (MALDI-TOF) mass spectrometer.
  • The OmegaTOF system couples Shimadzu's benchtop MALDI-TOF instrument platform (MALDI-8020) with established technology for high mass detection from CovalX.
  • The result is a user-friendly, compact platform that extends benchtop MALDI-TOF analysis to a mass range of 1.5 MegaDalton.

Nanalysis Appoints Dr. René Lenggenhager to Board of Directors

Retrieved on: 
Wednesday, December 15, 2021
Nuclear magnetic resonance, Forward-looking statement, University of St. Gallen, Law enforcement, Board of directors, OTC, Government, Physics, Company, ETH Zurich, Board, Doctor of Philosophy, MTD, Mettler Toledo, Automation, Growth, OTCQX, Industry, Agrochemical, Intention, CEO, Marketing, Comet Group, NMR, CovalX, NSCI, Offering, Indian stock exchange, Federal Institute of Science and Technology, AB, TSX Venture Exchange, Siemens Building Technologies, Multimedia, Legislation, University, Mining, Corporation, MRI, COTN, News, Technology, Security (finance), Management, Nanalysis

CALGARY, AB, Dec. 15, 2021 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ispleased to announce that, effective January 1, 2022, Dr. Ren Lenggenhager, is joining its Board of Directors.

Key Points: 
  • CALGARY, AB, Dec. 15, 2021 /PRNewswire/ - Nanalysis Scientific Corp. ("Nanalysis" or the "Company"), TSXV:NSCI , OTCQX:NSCIF, FRA:1N1) ispleased to announce that, effective January 1, 2022, Dr. Ren Lenggenhager, is joining its Board of Directors.
  • Dr. Lenggenhager is an experienced public company executive and board member with a successful career in leading global technology companies.
  • Dr. Ren Lenggenhager states, "I am enthusiastic about joining the Nanalysis team, at the Board level, and helping management continue to refine and focus its product strategy.
  • Chair of the Board of Directors, Mr. Martin Burian adds, "We welcome Ren to the Nanalysis Board of Directors, and look forward to working with him particularly in the context of our strategic evolution and growth.